ライフサイエンスコーパス: ventricular failure

1 -expressing mice, even prior to the onset of ventricular failure.

2 e animals that received L-NAME died of right ventricular failure.

3 was used as a molecular phenotypic marker of ventricular failure.

4 ancy with the development of angina and left ventricular failure.

5 ed, in contrast to what is described in left ventricular failure.

6 ascular resistance and, eventually, in right ventricular failure.

7 ling of the pulmonary vasculature, and right ventricular failure.

8 eath contributing to the progression of left ventricular failure.

9 artery pressure, often culminating in right ventricular failure.

10 can progress and result in progressive right ventricular failure.

11 t ventricular dysfunction and nine had right ventricular failure.

12 sfunction, pulmonary hypertension, and right ventricular failure.

13 tive heart failure died from refractory left ventricular failure.

14 ysiology, assessment and management of right ventricular failure.

15 es for the diagnosis and management of right ventricular failure.

16 ublished practice guideline focused on right ventricular failure.

17 to extensive left ventricular infarction and ventricular failure.

18 othoracic surgery, require therapy for right ventricular failure.

19 tients with pulmonary hypertension and right ventricular failure.

20 complicated by cardiogenic shock due to left ventricular failure.

21 death has been questioned as a mechanism of ventricular failure.

22 or beta(1)AR have resulted in phenotypes of ventricular failure.

23 R with 884 patients who had predominant left ventricular failure.

24 and early mortality due to systemic (right) ventricular failure.

25 on results in bradycardia and development of ventricular failure.

26 ction than patients under 60 years with left-ventricular failure.

27 dial infarction, Q wave infarction, and left-ventricular failure.

28 t were not associated with clinical systemic ventricular failure.

29 Predominant left ventricular failure (78.5%) was most common, with isolat

30 Right ventricular failure after LVAD surgery is associated wit

31 ry hypertension, which can progress to right ventricular failure, an important cause of morbidity and

32 nd banding of ascending aorta producing left ventricular failure and cardiogenic shock.

33 wave reflections in the pathogenesis of left ventricular failure and cardiovascular disease, but thei

34 ry arterial pressure, often leading to right ventricular failure and death.

35 iver transplantation (OLT) may develop right ventricular failure and death.

36 tion of pulmonary vascular resistance, right ventricular failure and death.

37 ary perfusion, ultimately resulting in right ventricular failure and dilation.

38 trials: the Prospective Randomized study Of Ventricular failure and Efficacy of Digoxin (PROVED) and

39 antially affected by the development of left-ventricular failure and other clinical indices, such tha

40 a higher incidence of post-transplant right ventricular failure and overall mortality (P<0.05).

41 size and pressure, and likely reflect right ventricular failure and overload.

42 es, leading to pulmonary hypertension, right ventricular failure, and death.

43 pulmonary arterial hypertension (PAH), right ventricular failure, and death.

44 ry arterioles, pulmonary hypertension, right ventricular failure, and death.

45 o elevated pulmonary-artery pressures, right-ventricular failure, and death.

46 increased pulmonary artery pressures, right ventricular failure, and death.

47 ely to develop complications related to left ventricular failure, and have improved early and late su

48 sulting in systemic hypertension, acute left ventricular failure, and multiple cardiac arrhythmias al

49 in their practice, but until recently right ventricular failure as a primary clinical entity receive

50 ently elevated in patients with chronic left ventricular failure as a result of dysregulation of vasc

51 pression of Galphaq develop progressive left ventricular failure associated with myocyte contractile

52 eta-blockers in patients with isolated right ventricular failure because of pulmonary arterial hypert

53 rative period were not attributable to right ventricular failure (chronic thromboembolic pulmonary hy

54 se, with higher rates of both for those with ventricular failure, compared with patients who had mech

55 Patients with shock due to left ventricular failure complicating myocardial infarction w

56 of the Glenn or Fontan procedure, including ventricular failure, cyanosis, protein-losing enteropath

57 hat in atrial myocytes from hearts with left ventricular failure, enhanced CaTs during ECC exert posi

58 reful perioperative attention to avoid right ventricular failure from acutely elevated pulmonary arte

59 Right ventricular failure from increased pulmonary vascular lo

60 Patients with CS caused by ventricular failure had more severe atherosclerosis, and

61 Patients aged 70 years or older without left-ventricular failure had significantly better survival at

62 tients who underwent angiography, those with ventricular failure had significantly lower in-hospital

63 rstanding of the mechanisms underlying right ventricular failure has improved.

64 es of impaired adrenergic signaling in right ventricular failure/hypertrophy (RVH) are poorly underst

65 ogressive SAVV regurgitation causes systemic ventricular failure in CCTGA patients, who are commonly

66 rious side effects were exacerbation of left ventricular failure in patients with congestive heart fa

67 if patient survival and mechanisms of right ventricular failure in pulmonary hypertension could be p

68 focus on the pathophysiology of acute right ventricular failure in the critical care setting and sum

69 ith low oxygen saturation; treatment of left ventricular failure in those with postcapillary pulmonar

70 ost common serious adverse events were right ventricular failure (in 3% of patients in each group) an

71 Importantly, for patients with ventricular failure, in-hospital mortality also correlat

72 n was associated with hemodynamic changes of ventricular failure including lower resting ejection fra

73 ccur, nor are there values below which right ventricular failure is always avoidable.

74 Left ventricular failure is associated with a decrease of myo

75 ble hemodynamic threshold beyond which right ventricular failure is certain to occur, nor are there v

76 Left ventricular failure is commonly preceded by a period of

77 Right ventricular failure is usually due to a combination of r

78 rial Registry patients with predominant left ventricular failure (LVF) were divided into four groups:

79 Right ventricular failure may be defined as the inability of t

80 ics, critical illness, intensive care, right ventricular failure, mitral stenosis, prostacyclin, nitr

81 ased pulmonary vascular resistance and right ventricular failure; morbidity and mortality remain unac

82 Right ventricular failure occurred in one third of patients an

83 cohort died of their disease; however, right ventricular failure or sudden death was the sole cause o

84 ted individuals are at risk of left or right ventricular failure, or both.

85 ted individuals are at risk of left or right ventricular failure, or both.

86 e cardiogenic shock is due primarily to left ventricular failure, other causes such as acute mitral r

87 post-heart transplantation in 22, and right ventricular failure post-implantable left VAD in 13.

88 Right ventricular failure predicts early mortality in patients

89 It is usually seen as a consequence of left ventricular failure, pulmonary embolism, pulmonary hyper

90 sing the search words right ventricle, right ventricular failure, pulmonary hypertension, sepsis, sho

91 Primary left ventricular failure resulting in death occurred in 2 pat

92 : age over 65 years, hypertension, diabetes, ventricular failure, rheumatic valvular disease, and pri

93 ratio>0.6) of whom four patients had a right ventricular failure (right ventricular end-diastolic are

94 Critical care specialists encounter right ventricular failure routinely in their practice, but unt

95 To review recent insights on right-ventricular failure (RVF) following left-ventricular ass

96 OF REVIEW: Pulmonary hypertension and right ventricular failure (RVF) in left ventricular systolic d

97 Right ventricular failure (RVF) in pulmonary hypertension (PH)

98 rowth hormone administered to rats with left ventricular failure starting 1 month after MI was associ

99 al work elucidating the pathobiology of left ventricular failure, there is a paucity of data on the c

100 overall and by shock etiology: left or right ventricular failure versus mechanical complications.

101 Right ventricular failure was defined as the need for post-ope

102 The severity of PAH and right ventricular failure was similar between those with and w

103 Left ventricular failure was the most common cause of death (

104 Left ventricular failure was the most frequent cause of CS fo

105 Left-ventricular failure was the strongest independent predic

106 Perioperative right ventricular failure was treated in most patients with in

107 Clinical systemic ventricular failure was uncommon, and at last follow-up,

108 tanding of the molecular mechanisms of right ventricular failure will lead to the development of new

109 h sudden cardiovascular collapse, acute left ventricular failure with pulmonary edema, disseminated i

110 except in cases of early perioperative right ventricular failure, with no deaths.